Geographic Atrophy

For years, #retina specialists have wrestled with a fundamental question in geographic atrophy: if visual acuity doesn’t improve, are we truly making an impact? In this conversation, the focus shifts from improvement to preservation. While #GA treatments may not restore vision, emerging data suggests something equally meaningful, slowing progression, preserving retinal tissue, and helping patients maintain functional vision longer. In a disease where central acuity doesn’t always tell the full story, tools like microperimetry and real-world observations are helping to reframe how we define success. The conversation reflects a broader shift in mindset: trusting the data, recognizing the nuances of GA, and continuing to push forward in understanding long-term impact. Because sometimes, maintaining vision is the win. To view the full discussion, click here: https://youtu.be/3UcEcFjq-dY?si=qFv3OCx-uyvWSo-C Editorially Independent Content with Support from Astellas Pharma